High impact
Polatuzumab Vedotin-piiq (Polivy) (CPB 0955, reviewed 2025-03-13)
Aetna·Effective Mar 13, 2025
HCPCS J9059 is officially defined as "Injection, bendamustine hydrochloride (baxter), 1 mg." HCPCS J9059 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9059 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.